Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Erdkamp

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|August 1, 1992
Pancreatitis induced by mesalamineF Erdkamp, M Houben, E Ackerman, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reportsB van Oijen, M Pleunis, F Erdkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancerS Chan, N Davidson, E Juozaityte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2013
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practiceK Krzemieniecki, P Sevelda, F Erdkamp, et al.
Investigational New Drugs|September 21, 2015
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patientsJ M Baas, L L Krens, A J ten Tije, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Anti-Cancer Drugs|May 18, 1999
Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center LimburgJ Wils, H van Geuns, J Stoot, et al.
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registryX G L V Pouwels, S M E Geurts, B L T Ramaekers, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|August 1, 1992
Pancreatitis induced by mesalamineF Erdkamp, M Houben, E Ackerman, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reportsB van Oijen, M Pleunis, F Erdkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancerS Chan, N Davidson, E Juozaityte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2013
Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practiceK Krzemieniecki, P Sevelda, F Erdkamp, et al.
Investigational New Drugs|September 21, 2015
Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patientsJ M Baas, L L Krens, A J ten Tije, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Anti-Cancer Drugs|May 18, 1999
Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center LimburgJ Wils, H van Geuns, J Stoot, et al.
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registryX G L V Pouwels, S M E Geurts, B L T Ramaekers, et al.
Pageof 1